Home > Insider Trading > Filing (0001209191-13-055517)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
924717	Surmodics Inc	SRDX	Surgical & Medical Instruments & Apparatus (3841)	411356149

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1412895	K Bryan Phillips	9924 West 74Th Street Eden Prairie MN 55344	Svp, Gen Counsel & Secretary	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-12-03	23,243	$9.25	42,997	No	4	M	Direct
Common Stock	Acquisiton	2013-12-03	10,735	$12.40	53,732	No	4	M	Direct
Common Stock	Disposition	2013-12-03	21,263	$23.47	32,469	No	4	F	Direct
Common Stock	Disposition	2013-12-04	16,236	$22.95	16,233	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2013-12-03	23,243	$0.00	23,243	$9.25
Common Stock	Stock Option (Right to Buy)	Disposition	2013-12-03	10,735	$0.00	10,735	$12.40

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
7,748		2017-11-30	No	4	D	Direct
10,734		2018-11-30	No	4	D	Direct

Footnotes

The reporting person makes a payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3.
The sales reported in this Form 4 were effected pursuant to a Rule 10b-5 trading plan adopted by the reporting person.
Reflects the weighted average price of 16,236 shares of common stock of SurModics, Inc. sold by the reporting person in multiple transactions on December 4, 2013 with the sale prices ranging from $22.59 to $23.415 per share. The reporting person undertakes to provide upon request by the U. S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
The award vests in four equal installments on each of the first four anniversaries of the November 30, 2010 grant date.
The award vests in four equal installments on each of the first four anniversaries of the November 30, 2011 grant date.